Brazil

Thu
29
Mar

Medical Marijuana, Inc. subsidiary HempMeds® Brazil provides CBD for university study in Brazil

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced the success of its subsidiary HempMeds® Brazil's Cannabis Symposium in Rio Grande do Sul, Brazil.

The event was put on in partnership with the National Association of Cannabidiol Users (ANUC) from March 19-23 and was held in the cities of Canoas, Passo Fundo and Porto Alegre.

There, Dr. Stuart Titus, CEO of Medical Marijuana, Inc., spoke about the benefits of cannabidiol (CBD) and also discussed upcoming potential research opportunities in Brazil.

Mon
14
Aug

MedReleaf Reports Q1 Fiscal 2018 Results

MedReleaf Corp. (TSX: LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced financial and operating results for the first quarter fiscal 2018 ending June 30, 2017. All amounts expressed are in Canadian dollars unless otherwise noted.

Wed
19
Jul

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis patients receive Brazilian government permission to be treated

Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds® Brasil today announced that the Company's hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ [RSHO™] has been prescribed by doctors in the country for the treatment of patients suffering from Amyotrophic Lateral Sclerosis (ALS) and Psoriasis.

Tue
16
May

Canadian Weed Producers Will Dominate the Global Marijuana Market

“First-mover advantage.” Why Canadian weed producers will dominate the global marijuana market.

In marketing strategy, there’s a term called “first-mover advantage”. It’s when a few key players in a particular industry gain an advantage because they entered into the marketplace first. These companies are able to establish strong brand recognition, shore up the best sources of funding, and build a loyal customer base simply because there aren’t any competitors in the way during their first few years of operation. 

Fri
05
May

The Global Marijuana March: Events Happening this Weekend

USA

New York City
Parade Assembly: 11:00 a.m. | West 31st & Broadway, Koreatown, NYC
Parade Start Time: 12:30 p.m. | Parade will march to Union Square (Route South on Broadway)
Rally: 1:00 p.m. – 5:00 p.m. | Union Square South Plaza
“The NYC Cannabis Parade is the longest running public expression of drug policy reform in New York City, with roots as far back as the early 70’s. This event have gone by many different monikers, but our purpose remains the same, to spread awareness throughout the world! In 1999, the Million Marijuana March brand exploded and has since turned into a annual event held in hundreds of cities across dozens of countries.”

Wed
08
Mar

The Legal International Cannabis Trade Already Exists, and We Mapped It

While the U.S. continues to squabble state-by-state over medical and adult use legalization, over the past year cannabis has quietly grown into a truly international industry.

Tue
14
Feb

Brazil Supreme Court Judge Calls for Drugs Legalization to Beat Gangs

A Brazilian Supreme Court justice called on Friday for the legalization of marijuana and even cocaine to undo the growing power of drug gangs behind a wave of violence that has shaken Latin America's largest country. 

Justice Roberto Barroso, a Yale graduate and constitutional law professor, said 50 years of war against drugs had failed miserably, clogging jails with small-time dealers and fueling a violent gang battle for control of the lucrative trade. 

Tue
17
Jan

Brazil Issues First License for Sale of a Cannabis-Based Drug

Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with patients.

The multiple sclerosis treatment, an oral spray derived from marijuana and developed by Britain's GW Pharmaceuticals PLC, is known as Sativex internationally and will be sold in Brazil under the brand name Mevatyl.

The legal status of cannabis-based drugs has been a thorny issue in Brazil for years, with several patients fighting in the courts to circumvent prohibition. Anvisa has loosened some restrictions in the past two years, allowing patients with medical orders to personally import some drugs derived from marijuana. 

Fri
06
Jan

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.

Thu
24
Nov

Bedrocan Canada Completes Export of Dried Cannabis to Brazil

Canopy Growth Corporation (Canopy Growth) (CGC) is pleased to provide the following update to its June 28, 2016 release on both the joint venture announcement with Entourage Phytolab (Entourage) and the formation of Bedrocan Brasil (Bedrocan Brasil), both companies partly owned by Canopy Growth Corporation.

First Export to South America

Canopy Growth's wholly-owned subsidiary Bedrocan Canada Inc. (Bedrocan Canada), has successfully exported 10 kg of dried cannabis to Brazil for research purposes. Securing a supply of standardized research grade cannabis is a major milestone in the Entourage clinical development plan and marks the first time to the Company's knowledge that medicinal cannabis from a Canadian Licensed Producer has been exported to South America.

Pages

Subscribe to RSS - Brazil